nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—Cytochrome P450 2D6 Inhibitors—Everolimus—kidney cancer	0.16	0.275	CiPCiCtD
Amiodarone—Cytochrome P450 2D6 Inhibitors—Pazopanib—kidney cancer	0.16	0.275	CiPCiCtD
Amiodarone—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.0921	0.158	CiPCiCtD
Amiodarone—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.0847	0.145	CiPCiCtD
Amiodarone—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.0847	0.145	CiPCiCtD
Amiodarone—CYP1A1—kidney cancer	0.0726	0.653	CbGaD
Amiodarone—ABCB1—kidney cancer	0.0386	0.347	CbGaD
Amiodarone—CYP3A7—Temsirolimus—kidney cancer	0.0136	0.0679	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0136	0.0679	CbGbCtD
Amiodarone—CYP3A5—Temsirolimus—kidney cancer	0.0102	0.051	CbGbCtD
Amiodarone—ABCB1—Temsirolimus—kidney cancer	0.00662	0.0332	CbGbCtD
Amiodarone—KCNH2—Sunitinib—kidney cancer	0.00655	0.0328	CbGbCtD
Amiodarone—CYP1A1—Erlotinib—kidney cancer	0.00635	0.0318	CbGbCtD
Amiodarone—CYP2D6—Temsirolimus—kidney cancer	0.00624	0.0313	CbGbCtD
Amiodarone—CYP3A4—Everolimus—kidney cancer	0.00587	0.0294	CbGbCtD
Amiodarone—CYP2C8—Pazopanib—kidney cancer	0.00514	0.0257	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00465	0.0233	CbGbCtD
Amiodarone—CYP3A7—Paclitaxel—kidney cancer	0.00465	0.0233	CbGbCtD
Amiodarone—CYP3A7—Sorafenib—kidney cancer	0.00413	0.0207	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00413	0.0207	CbGbCtD
Amiodarone—CYP3A7—Vincristine—kidney cancer	0.00401	0.0201	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00401	0.0201	CbGbCtD
Amiodarone—CYP1A2—Pazopanib—kidney cancer	0.00398	0.0199	CbGbCtD
Amiodarone—CYP3A4—Temsirolimus—kidney cancer	0.00397	0.0199	CbGbCtD
Amiodarone—CYP3A5—Erlotinib—kidney cancer	0.00381	0.0191	CbGbCtD
Amiodarone—CYP2C9—Capecitabine—kidney cancer	0.00374	0.0187	CbGbCtD
Amiodarone—CYP2C8—Erlotinib—kidney cancer	0.00366	0.0184	CbGbCtD
Amiodarone—CYP3A5—Paclitaxel—kidney cancer	0.00349	0.0175	CbGbCtD
Amiodarone—ABCB1—Pazopanib—kidney cancer	0.00348	0.0174	CbGbCtD
Amiodarone—CYP2C8—Paclitaxel—kidney cancer	0.00335	0.0168	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00335	0.0168	CbGbCtD
Amiodarone—CYP3A7—Sunitinib—kidney cancer	0.00335	0.0168	CbGbCtD
Amiodarone—CYP2D6—Pazopanib—kidney cancer	0.00328	0.0164	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—kidney cancer	0.00318	0.0159	CbGbCtD
Amiodarone—CYP3A5—Sorafenib—kidney cancer	0.0031	0.0155	CbGbCtD
Amiodarone—CYP3A5—Vincristine—kidney cancer	0.00301	0.0151	CbGbCtD
Amiodarone—CYP2C8—Sorafenib—kidney cancer	0.00298	0.0149	CbGbCtD
Amiodarone—CYP1A2—Erlotinib—kidney cancer	0.00284	0.0142	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—kidney cancer	0.00251	0.0126	CbGbCtD
Amiodarone—CYP3A5—Sunitinib—kidney cancer	0.00251	0.0126	CbGbCtD
Amiodarone—CYP2C19—Sorafenib—kidney cancer	0.0025	0.0125	CbGbCtD
Amiodarone—ABCB1—Erlotinib—kidney cancer	0.00248	0.0124	CbGbCtD
Amiodarone—CYP2C9—Paclitaxel—kidney cancer	0.00234	0.0117	CbGbCtD
Amiodarone—CYP2D6—Erlotinib—kidney cancer	0.00234	0.0117	CbGbCtD
Amiodarone—CYP1A2—Sorafenib—kidney cancer	0.00231	0.0116	CbGbCtD
Amiodarone—ABCB1—Paclitaxel—kidney cancer	0.00227	0.0114	CbGbCtD
Amiodarone—CYP3A4—Pazopanib—kidney cancer	0.00208	0.0104	CbGbCtD
Amiodarone—CYP2C9—Sorafenib—kidney cancer	0.00208	0.0104	CbGbCtD
Amiodarone—ABCB1—Sorafenib—kidney cancer	0.00202	0.0101	CbGbCtD
Amiodarone—ABCB1—Vinblastine—kidney cancer	0.00199	0.00998	CbGbCtD
Amiodarone—ABCB1—Vincristine—kidney cancer	0.00196	0.00981	CbGbCtD
Amiodarone—CYP2D6—Sorafenib—kidney cancer	0.0019	0.00953	CbGbCtD
Amiodarone—CYP2D6—Vinblastine—kidney cancer	0.00188	0.00941	CbGbCtD
Amiodarone—ABCB1—Sunitinib—kidney cancer	0.00163	0.00819	CbGbCtD
Amiodarone—CYP3A4—Erlotinib—kidney cancer	0.00149	0.00745	CbGbCtD
Amiodarone—CYP3A4—Paclitaxel—kidney cancer	0.00136	0.00682	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—kidney cancer	0.00122	0.00613	CbGbCtD
Amiodarone—CYP3A4—Sorafenib—kidney cancer	0.00121	0.00606	CbGbCtD
Amiodarone—CYP3A4—Vinblastine—kidney cancer	0.00119	0.00598	CbGbCtD
Amiodarone—CYP3A4—Vincristine—kidney cancer	0.00117	0.00588	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—kidney cancer	0.00115	0.00578	CbGbCtD
Amiodarone—CYP3A4—Sunitinib—kidney cancer	0.000979	0.00491	CbGbCtD
Amiodarone—CYP2C19—urine—kidney cancer	0.000792	0.0714	CbGeAlD
Amiodarone—CYP3A4—Doxorubicin—kidney cancer	0.000733	0.00368	CbGbCtD
Amiodarone—CYP1A2—urine—kidney cancer	0.000647	0.0583	CbGeAlD
Amiodarone—CYP2C9—urine—kidney cancer	0.000614	0.0553	CbGeAlD
Amiodarone—THRA—renal system—kidney cancer	0.000508	0.0457	CbGeAlD
Amiodarone—THRB—renal system—kidney cancer	0.000508	0.0457	CbGeAlD
Amiodarone—THRB—kidney—kidney cancer	0.000491	0.0442	CbGeAlD
Amiodarone—THRA—kidney—kidney cancer	0.000491	0.0442	CbGeAlD
Amiodarone—CYP3A4—urine—kidney cancer	0.000469	0.0422	CbGeAlD
Amiodarone—CYP2D6—urine—kidney cancer	0.000461	0.0415	CbGeAlD
Amiodarone—THRB—gonad—kidney cancer	0.000455	0.041	CbGeAlD
Amiodarone—THRA—gonad—kidney cancer	0.000455	0.041	CbGeAlD
Amiodarone—CACNA2D2—cardiac atrium—kidney cancer	0.00045	0.0405	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000406	0.0366	CbGeAlD
Amiodarone—CACNA1H—gonad—kidney cancer	0.000365	0.0329	CbGeAlD
Amiodarone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000347	0.0313	CbGeAlD
Amiodarone—EBP—Sirolimus—Temsirolimus—kidney cancer	0.000347	0.306	CbGdCrCtD
Amiodarone—EBP—Temsirolimus—Everolimus—kidney cancer	0.000347	0.306	CbGdCrCtD
Amiodarone—EBP—Sirolimus—Everolimus—kidney cancer	0.000347	0.306	CbGdCrCtD
Amiodarone—Oxybuprocaine—BCHE—kidney cancer	0.000321	0.457	CrCbGaD
Amiodarone—Cinchocaine—BCHE—kidney cancer	0.000285	0.406	CrCbGaD
Amiodarone—SIGMAR1—nephron tubule—kidney cancer	0.000256	0.023	CbGeAlD
Amiodarone—SIGMAR1—cortex of kidney—kidney cancer	0.000219	0.0197	CbGeAlD
Amiodarone—ADRB1—cardiac atrium—kidney cancer	0.000217	0.0195	CbGeAlD
Amiodarone—SIGMAR1—cardiac atrium—kidney cancer	0.000208	0.0187	CbGeAlD
Amiodarone—KCNH2—renal system—kidney cancer	0.000185	0.0167	CbGeAlD
Amiodarone—CYP2C8—renal system—kidney cancer	0.000169	0.0152	CbGeAlD
Amiodarone—CYP3A5—nephron tubule—kidney cancer	0.000168	0.0151	CbGeAlD
Amiodarone—KCNH2—cardiac atrium—kidney cancer	0.000166	0.0149	CbGeAlD
Amiodarone—CYP2C8—kidney—kidney cancer	0.000164	0.0147	CbGeAlD
Amiodarone—CYP1A2—renal system—kidney cancer	0.000158	0.0143	CbGeAlD
Amiodarone—CYP1A1—renal system—kidney cancer	0.000156	0.0141	CbGeAlD
Amiodarone—CYP3A5—renal system—kidney cancer	0.000153	0.0138	CbGeAlD
Amiodarone—CYP1A1—kidney—kidney cancer	0.000151	0.0136	CbGeAlD
Amiodarone—CYP3A5—kidney—kidney cancer	0.000148	0.0133	CbGeAlD
Amiodarone—CYP3A5—cortex of kidney—kidney cancer	0.000144	0.013	CbGeAlD
Amiodarone—CYP1A1—cardiac atrium—kidney cancer	0.00014	0.0126	CbGeAlD
Amiodarone—CYP3A4—renal system—kidney cancer	0.000115	0.0103	CbGeAlD
Amiodarone—CYP2D6—renal system—kidney cancer	0.000113	0.0102	CbGeAlD
Amiodarone—CYP3A4—kidney—kidney cancer	0.000111	0.00998	CbGeAlD
Amiodarone—CYP2D6—kidney—kidney cancer	0.000109	0.00982	CbGeAlD
Amiodarone—Dronedarone—ABCB1—kidney cancer	9.63e-05	0.137	CrCbGaD
Amiodarone—EBP—Azacitidine—Gemcitabine—kidney cancer	9.34e-05	0.0823	CbGdCrCtD
Amiodarone—ABCB1—nephron tubule—kidney cancer	8.93e-05	0.00804	CbGeAlD
Amiodarone—ABCB1—renal system—kidney cancer	8.11e-05	0.00731	CbGeAlD
Amiodarone—ABCB1—kidney—kidney cancer	7.84e-05	0.00706	CbGeAlD
Amiodarone—ABCB1—cortex of kidney—kidney cancer	7.64e-05	0.00688	CbGeAlD
Amiodarone—ABCB1—gonad—kidney cancer	7.28e-05	0.00655	CbGeAlD
Amiodarone—Renal impairment—Doxorubicin—kidney cancer	2.69e-05	0.00036	CcSEcCtD
Amiodarone—Paraesthesia—Vincristine—kidney cancer	2.69e-05	0.000359	CcSEcCtD
Amiodarone—Agitation—Paclitaxel—kidney cancer	2.67e-05	0.000358	CcSEcCtD
Amiodarone—Rash—Everolimus—kidney cancer	2.67e-05	0.000357	CcSEcCtD
Amiodarone—Dermatitis—Everolimus—kidney cancer	2.67e-05	0.000357	CcSEcCtD
Amiodarone—Headache—Vinblastine—kidney cancer	2.66e-05	0.000356	CcSEcCtD
Amiodarone—Angioedema—Paclitaxel—kidney cancer	2.66e-05	0.000356	CcSEcCtD
Amiodarone—Headache—Everolimus—kidney cancer	2.65e-05	0.000355	CcSEcCtD
Amiodarone—Hypotension—Gemcitabine—kidney cancer	2.65e-05	0.000355	CcSEcCtD
Amiodarone—Body temperature increased—Dactinomycin—kidney cancer	2.65e-05	0.000354	CcSEcCtD
Amiodarone—Abdominal pain—Dactinomycin—kidney cancer	2.65e-05	0.000354	CcSEcCtD
Amiodarone—Visual impairment—Capecitabine—kidney cancer	2.64e-05	0.000354	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Doxorubicin—kidney cancer	2.64e-05	0.000354	CcSEcCtD
Amiodarone—Asthenia—Sorafenib—kidney cancer	2.64e-05	0.000353	CcSEcCtD
Amiodarone—Malaise—Paclitaxel—kidney cancer	2.62e-05	0.000351	CcSEcCtD
Amiodarone—Cardiac failure—Doxorubicin—kidney cancer	2.62e-05	0.000351	CcSEcCtD
Amiodarone—Vertigo—Paclitaxel—kidney cancer	2.62e-05	0.00035	CcSEcCtD
Amiodarone—Hypersensitivity—Sunitinib—kidney cancer	2.61e-05	0.000349	CcSEcCtD
Amiodarone—Decreased appetite—Vincristine—kidney cancer	2.6e-05	0.000348	CcSEcCtD
Amiodarone—Pruritus—Sorafenib—kidney cancer	2.6e-05	0.000348	CcSEcCtD
Amiodarone—Vomiting—Erlotinib—kidney cancer	2.6e-05	0.000348	CcSEcCtD
Amiodarone—Erythema multiforme—Capecitabine—kidney cancer	2.59e-05	0.000347	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Vincristine—kidney cancer	2.58e-05	0.000346	CcSEcCtD
Amiodarone—Fatigue—Vincristine—kidney cancer	2.58e-05	0.000345	CcSEcCtD
Amiodarone—Rash—Erlotinib—kidney cancer	2.58e-05	0.000345	CcSEcCtD
Amiodarone—Dermatitis—Erlotinib—kidney cancer	2.57e-05	0.000344	CcSEcCtD
Amiodarone—Insomnia—Gemcitabine—kidney cancer	2.57e-05	0.000344	CcSEcCtD
Amiodarone—Headache—Erlotinib—kidney cancer	2.56e-05	0.000343	CcSEcCtD
Amiodarone—Tinnitus—Capecitabine—kidney cancer	2.56e-05	0.000342	CcSEcCtD
Amiodarone—Pain—Vincristine—kidney cancer	2.56e-05	0.000342	CcSEcCtD
Amiodarone—Constipation—Vincristine—kidney cancer	2.56e-05	0.000342	CcSEcCtD
Amiodarone—Paraesthesia—Gemcitabine—kidney cancer	2.55e-05	0.000341	CcSEcCtD
Amiodarone—Flushing—Capecitabine—kidney cancer	2.55e-05	0.000341	CcSEcCtD
Amiodarone—Cough—Paclitaxel—kidney cancer	2.54e-05	0.00034	CcSEcCtD
Amiodarone—Asthenia—Sunitinib—kidney cancer	2.54e-05	0.00034	CcSEcCtD
Amiodarone—Dyspnoea—Gemcitabine—kidney cancer	2.53e-05	0.000339	CcSEcCtD
Amiodarone—Nausea—Vinblastine—kidney cancer	2.52e-05	0.000338	CcSEcCtD
Amiodarone—Nausea—Everolimus—kidney cancer	2.51e-05	0.000337	CcSEcCtD
Amiodarone—Diarrhoea—Sorafenib—kidney cancer	2.51e-05	0.000337	CcSEcCtD
Amiodarone—Pruritus—Sunitinib—kidney cancer	2.5e-05	0.000335	CcSEcCtD
Amiodarone—Anxiety—Paclitaxel—kidney cancer	2.47e-05	0.000331	CcSEcCtD
Amiodarone—Decreased appetite—Gemcitabine—kidney cancer	2.47e-05	0.00033	CcSEcCtD
Amiodarone—Hypersensitivity—Dactinomycin—kidney cancer	2.47e-05	0.00033	CcSEcCtD
Amiodarone—Arrhythmia—Capecitabine—kidney cancer	2.45e-05	0.000328	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.45e-05	0.000328	CcSEcCtD
Amiodarone—Discomfort—Paclitaxel—kidney cancer	2.45e-05	0.000328	CcSEcCtD
Amiodarone—Fatigue—Gemcitabine—kidney cancer	2.45e-05	0.000327	CcSEcCtD
Amiodarone—Gastrointestinal pain—Vincristine—kidney cancer	2.45e-05	0.000327	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—kidney cancer	2.43e-05	0.000325	CcSEcCtD
Amiodarone—Dizziness—Sorafenib—kidney cancer	2.43e-05	0.000325	CcSEcCtD
Amiodarone—Constipation—Gemcitabine—kidney cancer	2.43e-05	0.000325	CcSEcCtD
Amiodarone—Pain—Gemcitabine—kidney cancer	2.43e-05	0.000325	CcSEcCtD
Amiodarone—Nausea—Erlotinib—kidney cancer	2.43e-05	0.000325	CcSEcCtD
Amiodarone—Alopecia—Capecitabine—kidney cancer	2.42e-05	0.000325	CcSEcCtD
Amiodarone—Dry mouth—Paclitaxel—kidney cancer	2.42e-05	0.000324	CcSEcCtD
Amiodarone—Diarrhoea—Sunitinib—kidney cancer	2.42e-05	0.000324	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—kidney cancer	2.4e-05	0.000322	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—kidney cancer	2.4e-05	0.000322	CcSEcCtD
Amiodarone—Confusional state—Paclitaxel—kidney cancer	2.4e-05	0.000321	CcSEcCtD
Amiodarone—Erythema—Capecitabine—kidney cancer	2.39e-05	0.00032	CcSEcCtD
Amiodarone—Anaphylactic shock—Paclitaxel—kidney cancer	2.38e-05	0.000318	CcSEcCtD
Amiodarone—Oedema—Paclitaxel—kidney cancer	2.38e-05	0.000318	CcSEcCtD
Amiodarone—Abdominal pain—Vincristine—kidney cancer	2.36e-05	0.000316	CcSEcCtD
Amiodarone—Body temperature increased—Vincristine—kidney cancer	2.36e-05	0.000316	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—kidney cancer	2.36e-05	0.000316	CcSEcCtD
Amiodarone—Infection—Paclitaxel—kidney cancer	2.36e-05	0.000316	CcSEcCtD
Amiodarone—Dysgeusia—Capecitabine—kidney cancer	2.34e-05	0.000313	CcSEcCtD
Amiodarone—Dizziness—Sunitinib—kidney cancer	2.34e-05	0.000313	CcSEcCtD
Amiodarone—Feeling abnormal—Gemcitabine—kidney cancer	2.34e-05	0.000313	CcSEcCtD
Amiodarone—Shock—Paclitaxel—kidney cancer	2.34e-05	0.000313	CcSEcCtD
Amiodarone—Vomiting—Sorafenib—kidney cancer	2.34e-05	0.000313	CcSEcCtD
Amiodarone—Thrombocytopenia—Paclitaxel—kidney cancer	2.33e-05	0.000311	CcSEcCtD
Amiodarone—Tachycardia—Paclitaxel—kidney cancer	2.32e-05	0.00031	CcSEcCtD
Amiodarone—Rash—Sorafenib—kidney cancer	2.32e-05	0.00031	CcSEcCtD
Amiodarone—Dermatitis—Sorafenib—kidney cancer	2.31e-05	0.00031	CcSEcCtD
Amiodarone—Back pain—Capecitabine—kidney cancer	2.31e-05	0.000309	CcSEcCtD
Amiodarone—Skin disorder—Paclitaxel—kidney cancer	2.31e-05	0.000309	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	2.3e-05	0.000308	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.3e-05	0.000308	CcSEcCtD
Amiodarone—Headache—Sorafenib—kidney cancer	2.3e-05	0.000308	CcSEcCtD
Amiodarone—Hyperhidrosis—Paclitaxel—kidney cancer	2.3e-05	0.000307	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—kidney cancer	2.29e-05	0.000307	CcSEcCtD
Amiodarone—Anorexia—Paclitaxel—kidney cancer	2.26e-05	0.000303	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—kidney cancer	2.26e-05	0.000302	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.26e-05	0.000302	CcSEcCtD
Amiodarone—Vision blurred—Capecitabine—kidney cancer	2.25e-05	0.000301	CcSEcCtD
Amiodarone—Vomiting—Sunitinib—kidney cancer	2.25e-05	0.000301	CcSEcCtD
Amiodarone—Body temperature increased—Gemcitabine—kidney cancer	2.24e-05	0.0003	CcSEcCtD
Amiodarone—Tremor—Capecitabine—kidney cancer	2.24e-05	0.0003	CcSEcCtD
Amiodarone—Rash—Sunitinib—kidney cancer	2.23e-05	0.000298	CcSEcCtD
Amiodarone—Dermatitis—Sunitinib—kidney cancer	2.23e-05	0.000298	CcSEcCtD
Amiodarone—Hypotension—Paclitaxel—kidney cancer	2.22e-05	0.000297	CcSEcCtD
Amiodarone—Ill-defined disorder—Capecitabine—kidney cancer	2.22e-05	0.000297	CcSEcCtD
Amiodarone—Headache—Sunitinib—kidney cancer	2.22e-05	0.000297	CcSEcCtD
Amiodarone—Hypersensitivity—Vincristine—kidney cancer	2.2e-05	0.000295	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—kidney cancer	2.19e-05	0.000293	CcSEcCtD
Amiodarone—Nausea—Sorafenib—kidney cancer	2.18e-05	0.000292	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—kidney cancer	2.17e-05	0.00029	CcSEcCtD
Amiodarone—Malaise—Capecitabine—kidney cancer	2.15e-05	0.000288	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—kidney cancer	2.15e-05	0.000288	CcSEcCtD
Amiodarone—Insomnia—Paclitaxel—kidney cancer	2.15e-05	0.000288	CcSEcCtD
Amiodarone—Vertigo—Capecitabine—kidney cancer	2.15e-05	0.000287	CcSEcCtD
Amiodarone—Asthenia—Vincristine—kidney cancer	2.15e-05	0.000287	CcSEcCtD
Amiodarone—Paraesthesia—Paclitaxel—kidney cancer	2.13e-05	0.000286	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—kidney cancer	2.13e-05	0.000285	CcSEcCtD
Amiodarone—Dyspnoea—Paclitaxel—kidney cancer	2.12e-05	0.000283	CcSEcCtD
Amiodarone—Rash—Dactinomycin—kidney cancer	2.11e-05	0.000283	CcSEcCtD
Amiodarone—Nausea—Sunitinib—kidney cancer	2.1e-05	0.000281	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—kidney cancer	2.1e-05	0.000281	CcSEcCtD
Amiodarone—Dyspepsia—Paclitaxel—kidney cancer	2.09e-05	0.00028	CcSEcCtD
Amiodarone—Cough—Capecitabine—kidney cancer	2.08e-05	0.000279	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—kidney cancer	2.07e-05	0.000277	CcSEcCtD
Amiodarone—Decreased appetite—Paclitaxel—kidney cancer	2.07e-05	0.000276	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.05e-05	0.000275	CcSEcCtD
Amiodarone—Fatigue—Paclitaxel—kidney cancer	2.05e-05	0.000274	CcSEcCtD
Amiodarone—Diarrhoea—Vincristine—kidney cancer	2.05e-05	0.000274	CcSEcCtD
Amiodarone—Asthenia—Gemcitabine—kidney cancer	2.04e-05	0.000272	CcSEcCtD
Amiodarone—Pain—Paclitaxel—kidney cancer	2.03e-05	0.000272	CcSEcCtD
Amiodarone—Constipation—Paclitaxel—kidney cancer	2.03e-05	0.000272	CcSEcCtD
Amiodarone—Anxiety—Capecitabine—kidney cancer	2.03e-05	0.000271	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—kidney cancer	2.02e-05	0.00027	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—kidney cancer	2.01e-05	0.000269	CcSEcCtD
Amiodarone—Discomfort—Capecitabine—kidney cancer	2.01e-05	0.000269	CcSEcCtD
Amiodarone—Pruritus—Gemcitabine—kidney cancer	2.01e-05	0.000269	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—kidney cancer	2e-05	0.000268	CcSEcCtD
Amiodarone—Dry mouth—Capecitabine—kidney cancer	1.99e-05	0.000266	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—kidney cancer	1.99e-05	0.000266	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—kidney cancer	1.98e-05	0.000265	CcSEcCtD
Amiodarone—Dizziness—Vincristine—kidney cancer	1.98e-05	0.000265	CcSEcCtD
Amiodarone—Confusional state—Capecitabine—kidney cancer	1.97e-05	0.000263	CcSEcCtD
Amiodarone—Feeling abnormal—Paclitaxel—kidney cancer	1.96e-05	0.000262	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.95e-05	0.000261	CcSEcCtD
Amiodarone—Oedema—Capecitabine—kidney cancer	1.95e-05	0.000261	CcSEcCtD
Amiodarone—Gastrointestinal pain—Paclitaxel—kidney cancer	1.94e-05	0.00026	CcSEcCtD
Amiodarone—Diarrhoea—Gemcitabine—kidney cancer	1.94e-05	0.00026	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—kidney cancer	1.94e-05	0.000259	CcSEcCtD
Amiodarone—Infection—Capecitabine—kidney cancer	1.94e-05	0.000259	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—kidney cancer	1.93e-05	0.000259	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—kidney cancer	1.92e-05	0.000257	CcSEcCtD
Amiodarone—Shock—Capecitabine—kidney cancer	1.92e-05	0.000257	CcSEcCtD
Amiodarone—Thrombocytopenia—Capecitabine—kidney cancer	1.91e-05	0.000255	CcSEcCtD
Amiodarone—Tachycardia—Capecitabine—kidney cancer	1.9e-05	0.000255	CcSEcCtD
Amiodarone—Vomiting—Vincristine—kidney cancer	1.9e-05	0.000255	CcSEcCtD
Amiodarone—Skin disorder—Capecitabine—kidney cancer	1.89e-05	0.000253	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—kidney cancer	1.89e-05	0.000253	CcSEcCtD
Amiodarone—Urticaria—Paclitaxel—kidney cancer	1.89e-05	0.000253	CcSEcCtD
Amiodarone—Rash—Vincristine—kidney cancer	1.89e-05	0.000252	CcSEcCtD
Amiodarone—Hyperhidrosis—Capecitabine—kidney cancer	1.88e-05	0.000252	CcSEcCtD
Amiodarone—Dermatitis—Vincristine—kidney cancer	1.88e-05	0.000252	CcSEcCtD
Amiodarone—Body temperature increased—Paclitaxel—kidney cancer	1.88e-05	0.000251	CcSEcCtD
Amiodarone—Abdominal pain—Paclitaxel—kidney cancer	1.88e-05	0.000251	CcSEcCtD
Amiodarone—Headache—Vincristine—kidney cancer	1.87e-05	0.000251	CcSEcCtD
Amiodarone—Anorexia—Capecitabine—kidney cancer	1.86e-05	0.000249	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—kidney cancer	1.84e-05	0.000246	CcSEcCtD
Amiodarone—Hypotension—Capecitabine—kidney cancer	1.82e-05	0.000244	CcSEcCtD
Amiodarone—Vomiting—Gemcitabine—kidney cancer	1.8e-05	0.000241	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—kidney cancer	1.8e-05	0.000241	CcSEcCtD
Amiodarone—Rash—Gemcitabine—kidney cancer	1.79e-05	0.000239	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—kidney cancer	1.79e-05	0.000239	CcSEcCtD
Amiodarone—Headache—Gemcitabine—kidney cancer	1.78e-05	0.000238	CcSEcCtD
Amiodarone—Nausea—Vincristine—kidney cancer	1.78e-05	0.000238	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—kidney cancer	1.77e-05	0.000237	CcSEcCtD
Amiodarone—Insomnia—Capecitabine—kidney cancer	1.76e-05	0.000236	CcSEcCtD
Amiodarone—Paraesthesia—Capecitabine—kidney cancer	1.75e-05	0.000234	CcSEcCtD
Amiodarone—Hypersensitivity—Paclitaxel—kidney cancer	1.75e-05	0.000234	CcSEcCtD
Amiodarone—Dyspnoea—Capecitabine—kidney cancer	1.74e-05	0.000233	CcSEcCtD
Amiodarone—Dyspepsia—Capecitabine—kidney cancer	1.72e-05	0.00023	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—kidney cancer	1.7e-05	0.000228	CcSEcCtD
Amiodarone—Asthenia—Paclitaxel—kidney cancer	1.7e-05	0.000228	CcSEcCtD
Amiodarone—Decreased appetite—Capecitabine—kidney cancer	1.69e-05	0.000227	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—kidney cancer	1.69e-05	0.000226	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Capecitabine—kidney cancer	1.68e-05	0.000225	CcSEcCtD
Amiodarone—Fatigue—Capecitabine—kidney cancer	1.68e-05	0.000225	CcSEcCtD
Amiodarone—Pruritus—Paclitaxel—kidney cancer	1.68e-05	0.000225	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—kidney cancer	1.67e-05	0.000224	CcSEcCtD
Amiodarone—Pain—Capecitabine—kidney cancer	1.67e-05	0.000223	CcSEcCtD
Amiodarone—Constipation—Capecitabine—kidney cancer	1.67e-05	0.000223	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—kidney cancer	1.65e-05	0.000221	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—kidney cancer	1.64e-05	0.00022	CcSEcCtD
Amiodarone—Diarrhoea—Paclitaxel—kidney cancer	1.63e-05	0.000218	CcSEcCtD
Amiodarone—Feeling abnormal—Capecitabine—kidney cancer	1.61e-05	0.000215	CcSEcCtD
Amiodarone—Gastrointestinal pain—Capecitabine—kidney cancer	1.59e-05	0.000213	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—kidney cancer	1.58e-05	0.000212	CcSEcCtD
Amiodarone—Dizziness—Paclitaxel—kidney cancer	1.57e-05	0.00021	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—kidney cancer	1.56e-05	0.000209	CcSEcCtD
Amiodarone—Urticaria—Capecitabine—kidney cancer	1.55e-05	0.000207	CcSEcCtD
Amiodarone—Body temperature increased—Capecitabine—kidney cancer	1.54e-05	0.000206	CcSEcCtD
Amiodarone—Abdominal pain—Capecitabine—kidney cancer	1.54e-05	0.000206	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—kidney cancer	1.54e-05	0.000206	CcSEcCtD
Amiodarone—Vomiting—Paclitaxel—kidney cancer	1.51e-05	0.000202	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—kidney cancer	1.51e-05	0.000202	CcSEcCtD
Amiodarone—Rash—Paclitaxel—kidney cancer	1.5e-05	0.0002	CcSEcCtD
Amiodarone—Dermatitis—Paclitaxel—kidney cancer	1.5e-05	0.0002	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—kidney cancer	1.49e-05	0.000199	CcSEcCtD
Amiodarone—Headache—Paclitaxel—kidney cancer	1.49e-05	0.000199	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—kidney cancer	1.45e-05	0.000194	CcSEcCtD
Amiodarone—Hypersensitivity—Capecitabine—kidney cancer	1.44e-05	0.000192	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—kidney cancer	1.43e-05	0.000191	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—kidney cancer	1.41e-05	0.000189	CcSEcCtD
Amiodarone—Nausea—Paclitaxel—kidney cancer	1.41e-05	0.000189	CcSEcCtD
Amiodarone—Asthenia—Capecitabine—kidney cancer	1.4e-05	0.000187	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—kidney cancer	1.39e-05	0.000186	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—kidney cancer	1.38e-05	0.000185	CcSEcCtD
Amiodarone—Pruritus—Capecitabine—kidney cancer	1.38e-05	0.000185	CcSEcCtD
Amiodarone—Cough—Doxorubicin—kidney cancer	1.34e-05	0.00018	CcSEcCtD
Amiodarone—Diarrhoea—Capecitabine—kidney cancer	1.33e-05	0.000179	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—kidney cancer	1.31e-05	0.000175	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—kidney cancer	1.3e-05	0.000173	CcSEcCtD
Amiodarone—Dizziness—Capecitabine—kidney cancer	1.29e-05	0.000173	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—kidney cancer	1.28e-05	0.000172	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—kidney cancer	1.27e-05	0.00017	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—kidney cancer	1.26e-05	0.000168	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—kidney cancer	1.26e-05	0.000168	CcSEcCtD
Amiodarone—Infection—Doxorubicin—kidney cancer	1.25e-05	0.000167	CcSEcCtD
Amiodarone—Vomiting—Capecitabine—kidney cancer	1.24e-05	0.000166	CcSEcCtD
Amiodarone—Shock—Doxorubicin—kidney cancer	1.24e-05	0.000165	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—kidney cancer	1.23e-05	0.000165	CcSEcCtD
Amiodarone—Rash—Capecitabine—kidney cancer	1.23e-05	0.000165	CcSEcCtD
Amiodarone—Dermatitis—Capecitabine—kidney cancer	1.23e-05	0.000164	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—kidney cancer	1.23e-05	0.000164	CcSEcCtD
Amiodarone—Headache—Capecitabine—kidney cancer	1.22e-05	0.000163	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—kidney cancer	1.22e-05	0.000163	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—kidney cancer	1.21e-05	0.000163	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—kidney cancer	1.2e-05	0.00016	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—kidney cancer	1.17e-05	0.000157	CcSEcCtD
Amiodarone—Nausea—Capecitabine—kidney cancer	1.16e-05	0.000155	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—kidney cancer	1.14e-05	0.000152	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—kidney cancer	1.13e-05	0.000151	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—kidney cancer	1.12e-05	0.00015	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—kidney cancer	1.11e-05	0.000148	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—kidney cancer	1.09e-05	0.000146	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.08e-05	0.000145	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—kidney cancer	1.08e-05	0.000145	CcSEcCtD
Amiodarone—Pain—Doxorubicin—kidney cancer	1.07e-05	0.000144	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—kidney cancer	1.07e-05	0.000144	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—kidney cancer	1.04e-05	0.000139	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—kidney cancer	1.03e-05	0.000138	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—kidney cancer	9.98e-06	0.000134	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—kidney cancer	9.93e-06	0.000133	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—kidney cancer	9.93e-06	0.000133	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—kidney cancer	9.26e-06	0.000124	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—kidney cancer	9.02e-06	0.000121	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—kidney cancer	8.89e-06	0.000119	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—kidney cancer	8.6e-06	0.000115	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—kidney cancer	8.31e-06	0.000111	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—kidney cancer	7.99e-06	0.000107	CcSEcCtD
Amiodarone—Rash—Doxorubicin—kidney cancer	7.92e-06	0.000106	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—kidney cancer	7.92e-06	0.000106	CcSEcCtD
Amiodarone—Headache—Doxorubicin—kidney cancer	7.87e-06	0.000105	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—kidney cancer	7.46e-06	9.99e-05	CcSEcCtD
Amiodarone—CYP3A5—Metabolism—GSTT1—kidney cancer	2.87e-06	0.000147	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CA9—kidney cancer	2.83e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PGK1—kidney cancer	2.82e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.82e-06	0.000145	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CA9—kidney cancer	2.81e-06	0.000144	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.8e-06	0.000144	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—LDHB—kidney cancer	2.77e-06	0.000142	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTP1—kidney cancer	2.76e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.75e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.74e-06	0.000141	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ITPR2—kidney cancer	2.73e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SCARB1—kidney cancer	2.72e-06	0.00014	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTT1—kidney cancer	2.71e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ACHE—kidney cancer	2.71e-06	0.000139	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS1—kidney cancer	2.69e-06	0.000138	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APRT—kidney cancer	2.67e-06	0.000137	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—FH—kidney cancer	2.67e-06	0.000137	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—POMC—kidney cancer	2.66e-06	0.000136	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PSMD7—kidney cancer	2.64e-06	0.000135	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CRABP1—kidney cancer	2.62e-06	0.000134	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ABCB1—kidney cancer	2.61e-06	0.000134	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.58e-06	0.000132	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SCARB1—kidney cancer	2.57e-06	0.000132	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CRABP1—kidney cancer	2.56e-06	0.000131	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS1—kidney cancer	2.54e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTM1—kidney cancer	2.53e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTP1—kidney cancer	2.53e-06	0.00013	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.52e-06	0.000129	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PIK3CA—kidney cancer	2.51e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPC3—kidney cancer	2.51e-06	0.000129	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—BCHE—kidney cancer	2.5e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PSMD7—kidney cancer	2.49e-06	0.000128	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.49e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTT1—kidney cancer	2.49e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ACHE—kidney cancer	2.49e-06	0.000128	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC5A5—kidney cancer	2.47e-06	0.000127	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CA2—kidney cancer	2.45e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ITPR2—kidney cancer	2.44e-06	0.000125	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CRABP1—kidney cancer	2.41e-06	0.000124	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CA9—kidney cancer	2.4e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP1A1—kidney cancer	2.4e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ABCB1—kidney cancer	2.39e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CRABP1—kidney cancer	2.39e-06	0.000123	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SLC2A1—kidney cancer	2.39e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALAD—kidney cancer	2.38e-06	0.000122	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ITPR2—kidney cancer	2.38e-06	0.000122	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—BCHE—kidney cancer	2.36e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SCARB1—kidney cancer	2.36e-06	0.000121	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF2—kidney cancer	2.35e-06	0.000121	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.35e-06	0.00012	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN2B—kidney cancer	2.34e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC5A5—kidney cancer	2.34e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS1—kidney cancer	2.33e-06	0.00012	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.33e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTM1—kidney cancer	2.32e-06	0.000119	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PSMD7—kidney cancer	2.29e-06	0.000117	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1R—kidney cancer	2.27e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.27e-06	0.000117	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC2A1—kidney cancer	2.26e-06	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.25e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ITPR2—kidney cancer	2.24e-06	0.000115	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTT1—kidney cancer	2.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ACHE—kidney cancer	2.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ITPR2—kidney cancer	2.22e-06	0.000114	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP1A1—kidney cancer	2.2e-06	0.000113	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RAF1—kidney cancer	2.19e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.19e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.18e-06	0.000112	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PGK1—kidney cancer	2.18e-06	0.000112	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ACHE—kidney cancer	2.17e-06	0.000111	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTT1—kidney cancer	2.17e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BCHE—kidney cancer	2.17e-06	0.000111	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—kidney cancer	2.16e-06	0.000111	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC5A5—kidney cancer	2.14e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LDHB—kidney cancer	2.14e-06	0.00011	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SCARB1—kidney cancer	2.1e-06	0.000108	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS1—kidney cancer	2.08e-06	0.000107	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC2A1—kidney cancer	2.07e-06	0.000106	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SCARB1—kidney cancer	2.05e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.05e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ACHE—kidney cancer	2.04e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTT1—kidney cancer	2.04e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CRABP1—kidney cancer	2.04e-06	0.000105	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PSMD7—kidney cancer	2.04e-06	0.000105	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS1—kidney cancer	2.03e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ACHE—kidney cancer	2.03e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTT1—kidney cancer	2.03e-06	0.000104	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.01e-06	0.000103	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PSMD7—kidney cancer	1.99e-06	0.000102	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—kidney cancer	1.99e-06	0.000102	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—kidney cancer	1.96e-06	0.000101	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BCHE—kidney cancer	1.94e-06	9.93e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SCARB1—kidney cancer	1.93e-06	9.92e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SCARB1—kidney cancer	1.92e-06	9.83e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS1—kidney cancer	1.91e-06	9.82e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.91e-06	9.8e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.91e-06	9.79e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ITPR2—kidney cancer	1.9e-06	9.74e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS1—kidney cancer	1.9e-06	9.74e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BCHE—kidney cancer	1.89e-06	9.69e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ABCB1—kidney cancer	1.89e-06	9.67e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—kidney cancer	1.88e-06	9.65e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PSMD7—kidney cancer	1.88e-06	9.63e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HIF1A—kidney cancer	1.87e-06	9.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TSC2—kidney cancer	1.87e-06	9.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—kidney cancer	1.87e-06	9.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PSMD7—kidney cancer	1.86e-06	9.55e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CA9—kidney cancer	1.85e-06	9.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.85e-06	9.47e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTM1—kidney cancer	1.83e-06	9.39e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC2A1—kidney cancer	1.8e-06	9.24e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.79e-06	9.19e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KDR—kidney cancer	1.79e-06	9.18e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—POMC—kidney cancer	1.79e-06	9.18e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ABCB1—kidney cancer	1.78e-06	9.14e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BCHE—kidney cancer	1.78e-06	9.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BCHE—kidney cancer	1.76e-06	9.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.76e-06	9.02e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.75e-06	8.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.75e-06	8.98e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.74e-06	8.94e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.73e-06	8.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTT1—kidney cancer	1.73e-06	8.88e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ACHE—kidney cancer	1.73e-06	8.88e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTM1—kidney cancer	1.73e-06	8.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—kidney cancer	1.72e-06	8.85e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.72e-06	8.81e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.7e-06	8.71e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.68e-06	8.63e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—kidney cancer	1.65e-06	8.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KIT—kidney cancer	1.65e-06	8.46e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—POMC—kidney cancer	1.64e-06	8.41e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SCARB1—kidney cancer	1.64e-06	8.4e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.63e-06	8.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—kidney cancer	1.63e-06	8.38e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS1—kidney cancer	1.62e-06	8.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PSMD7—kidney cancer	1.59e-06	8.16e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—kidney cancer	1.59e-06	8.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—kidney cancer	1.58e-06	8.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CRABP1—kidney cancer	1.58e-06	8.08e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—POMC—kidney cancer	1.57e-06	8.05e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.56e-06	8.01e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—kidney cancer	1.55e-06	7.95e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—kidney cancer	1.54e-06	7.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BCHE—kidney cancer	1.51e-06	7.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK1—kidney cancer	1.5e-06	7.71e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—kidney cancer	1.5e-06	7.71e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.5e-06	7.71e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.49e-06	7.64e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ITPR2—kidney cancer	1.46e-06	7.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—kidney cancer	1.46e-06	7.48e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.44e-06	7.38e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—kidney cancer	1.44e-06	7.37e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—kidney cancer	1.43e-06	7.32e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.42e-06	7.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—kidney cancer	1.42e-06	7.28e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—kidney cancer	1.42e-06	7.26e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—kidney cancer	1.41e-06	7.26e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—kidney cancer	1.4e-06	7.2e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.4e-06	7.16e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—kidney cancer	1.38e-06	7.08e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.35e-06	6.91e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.34e-06	6.88e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—kidney cancer	1.34e-06	6.88e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ACHE—kidney cancer	1.34e-06	6.85e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—kidney cancer	1.34e-06	6.85e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—kidney cancer	1.33e-06	6.82e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP1A1—kidney cancer	1.31e-06	6.72e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—kidney cancer	1.31e-06	6.71e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—kidney cancer	1.3e-06	6.69e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—kidney cancer	1.3e-06	6.68e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAF1—kidney cancer	1.29e-06	6.64e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POMC—kidney cancer	1.29e-06	6.64e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—kidney cancer	1.29e-06	6.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RELA—kidney cancer	1.29e-06	6.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—kidney cancer	1.28e-06	6.57e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SCARB1—kidney cancer	1.26e-06	6.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—kidney cancer	1.26e-06	6.48e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS1—kidney cancer	1.25e-06	6.42e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—kidney cancer	1.24e-06	6.39e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.23e-06	6.33e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.23e-06	6.33e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PSMD7—kidney cancer	1.23e-06	6.3e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.22e-06	6.27e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POMC—kidney cancer	1.22e-06	6.27e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.22e-06	6.24e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—kidney cancer	1.2e-06	6.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	1.19e-06	6.08e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—kidney cancer	1.16e-06	5.97e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—kidney cancer	1.16e-06	5.95e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.15e-06	5.9e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—kidney cancer	1.14e-06	5.85e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—kidney cancer	1.14e-06	5.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—kidney cancer	1.13e-06	5.8e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—kidney cancer	1.13e-06	5.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	1.12e-06	5.75e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POMC—kidney cancer	1.12e-06	5.75e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.11e-06	5.69e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—kidney cancer	1.1e-06	5.66e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.1e-06	5.65e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—kidney cancer	1.09e-06	5.6e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.05e-06	5.36e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—kidney cancer	1.03e-06	5.29e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1e-06	5.15e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POMC—kidney cancer	1e-06	5.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—kidney cancer	9.86e-07	5.06e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POMC—kidney cancer	9.76e-07	5.01e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—kidney cancer	9.75e-07	5e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—kidney cancer	9.33e-07	4.79e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—kidney cancer	9.26e-07	4.75e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POMC—kidney cancer	9.2e-07	4.72e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POMC—kidney cancer	9.12e-07	4.68e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—kidney cancer	9.08e-07	4.66e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—kidney cancer	9e-07	4.62e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—kidney cancer	8.94e-07	4.58e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK1—kidney cancer	8.88e-07	4.55e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—kidney cancer	8.78e-07	4.5e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—kidney cancer	8.76e-07	4.5e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.59e-07	4.4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—kidney cancer	8.51e-07	4.36e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—kidney cancer	8.5e-07	4.36e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—kidney cancer	8.39e-07	4.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.07e-07	4.14e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—kidney cancer	8.05e-07	4.13e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—kidney cancer	7.98e-07	4.09e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—kidney cancer	7.79e-07	4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POMC—kidney cancer	7.79e-07	4e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—kidney cancer	7.79e-07	3.99e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	7.7e-07	3.95e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—kidney cancer	7.45e-07	3.82e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—kidney cancer	7.34e-07	3.76e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—kidney cancer	7.27e-07	3.73e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—kidney cancer	6.96e-07	3.57e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—kidney cancer	6.79e-07	3.48e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—kidney cancer	6.4e-07	3.28e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—kidney cancer	6.35e-07	3.26e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—kidney cancer	6.34e-07	3.25e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—kidney cancer	6.22e-07	3.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POMC—kidney cancer	6.01e-07	3.08e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—kidney cancer	6e-07	3.08e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—kidney cancer	5.5e-07	2.82e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—kidney cancer	5.42e-07	2.78e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—kidney cancer	4.91e-07	2.52e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—kidney cancer	4.8e-07	2.46e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—kidney cancer	4.79e-07	2.46e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—kidney cancer	4.51e-07	2.32e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.47e-07	2.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—kidney cancer	4.18e-07	2.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.82e-07	1.96e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.95e-07	1.51e-05	CbGpPWpGaD
